270 related articles for article (PubMed ID: 34224371)
41. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
[TBL] [Abstract][Full Text] [Related]
42. Higher densities of Foxp3
Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
[TBL] [Abstract][Full Text] [Related]
43. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
Jelinek DF; Splawski JB; Lipsky PE
J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
[TBL] [Abstract][Full Text] [Related]
44. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.
Zirakzadeh AA; Marits P; Sherif A; Winqvist O
J Immunol; 2013 Jun; 190(11):5847-55. PubMed ID: 23630345
[TBL] [Abstract][Full Text] [Related]
45. Intratumoral CD103-positive tumour-infiltrating lymphocytes are associated with favourable prognosis in patients with triple-negative breast cancer.
Park MH; Kwon SY; Choi JE; Gong G; Bae YK
Histopathology; 2020 Oct; 77(4):560-569. PubMed ID: 32333690
[TBL] [Abstract][Full Text] [Related]
46. Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.
Forero A; Li Y; Chen D; Grizzle WE; Updike KL; Merz ND; Downs-Kelly E; Burwell TC; Vaklavas C; Buchsbaum DJ; Myers RM; LoBuglio AF; Varley KE
Cancer Immunol Res; 2016 May; 4(5):390-9. PubMed ID: 26980599
[TBL] [Abstract][Full Text] [Related]
47. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
48. Double-negative (CD27
Centuori SM; Gomes CJ; Kim SS; Putnam CW; Larsen BT; Garland LL; Mount DW; Martinez JD
J Transl Med; 2018 Feb; 16(1):30. PubMed ID: 29448960
[TBL] [Abstract][Full Text] [Related]
49. High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs.
Onagi H; Horimoto Y; Sakaguchi A; Ikarashi D; Yanagisawa N; Nakayama T; Nakatsura T; Ishizuka Y; Sasaki R; Watanabe J; Saito M; Saeki H; Hayashi T; Arakawa A; Yao T; Kitano S
Breast Cancer Res; 2022 Oct; 24(1):67. PubMed ID: 36217150
[TBL] [Abstract][Full Text] [Related]
50. PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer.
Ren X; Wu H; Lu J; Zhang Y; Luo Y; Xu Q; Shen S; Liang Z
Cancer Biol Ther; 2018 May; 19(5):373-380. PubMed ID: 29336717
[TBL] [Abstract][Full Text] [Related]
51. Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
Song IH; Heo SH; Bang WS; Park HS; Park IA; Kim YA; Park SY; Roh J; Gong G; Lee HJ
Cancer Res Treat; 2017 Apr; 49(2):399-407. PubMed ID: 27488875
[TBL] [Abstract][Full Text] [Related]
52. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA
Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360
[TBL] [Abstract][Full Text] [Related]
53. Tracking Immunoglobulin Repertoire and Transcriptomic Changes in Germinal Center B Cells by Single-Cell Analysis.
Corinaldesi C; Holmes AB; Shen Q; Grunstein E; Pasqualucci L; Dalla-Favera R; Basso K
Front Immunol; 2021; 12():818758. PubMed ID: 35095922
[TBL] [Abstract][Full Text] [Related]
54. BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Solinas C; Marcoux D; Garaud S; Vitória JR; Van den Eynden G; de Wind A; De Silva P; Boisson A; Craciun L; Larsimont D; Piccart-Gebhart M; Detours V; t'Kint de Roodenbeke D; Willard-Gallo K
Cancer Lett; 2019 May; 450():88-97. PubMed ID: 30797818
[TBL] [Abstract][Full Text] [Related]
55. Most B cells that have switched surface immunoglobulin isotypes generate clones of cells that do not secrete IgM.
Gearhart PJ; Cebra JJ
J Immunol; 1981 Sep; 127(3):1030-4. PubMed ID: 6790608
[TBL] [Abstract][Full Text] [Related]
56. CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
Oshi M; Asaoka M; Tokumaru Y; Yan L; Matsuyama R; Ishikawa T; Endo I; Takabe K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971948
[TBL] [Abstract][Full Text] [Related]
57. Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
Park IA; Hwang SH; Song IH; Heo SH; Kim YA; Bang WS; Park HS; Lee M; Gong G; Lee HJ
PLoS One; 2017; 12(8):e0182786. PubMed ID: 28817603
[TBL] [Abstract][Full Text] [Related]
58. TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors.
Bou-Dargham MJ; Sha L; Sarker DB; Krakora-Compagno MZ; Chen Z; Zhang J; Sang QA
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298307
[TBL] [Abstract][Full Text] [Related]
59. 4-1BB-Enhanced Expansion of CD8
Harao M; Forget MA; Roszik J; Gao H; Babiera GV; Krishnamurthy S; Chacon JA; Li S; Mittendorf EA; DeSnyder SM; Rockwood KF; Bernatchez C; Ueno NT; Radvanyi LG; Vence L; Haymaker C; Reuben JM
Cancer Immunol Res; 2017 Jun; 5(6):439-445. PubMed ID: 28473315
[TBL] [Abstract][Full Text] [Related]
60. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
